| scholarly article | Q13442814 |
| P50 | author | Walter Alberto Sifuentes Giraldo | Q51052399 |
| P2093 | author name string | María Jesús García Villanueva | |
| María Ahijón Lana | |||
| Carmen González García | |||
| Mónica Vázquez Diaz | |||
| P2860 | cites work | Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey | Q24816756 |
| The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications | Q36373315 | ||
| Drug-induced lupus due to anti-tumor necrosis factor alpha agents | Q36989060 | ||
| Pathogenic anti-nucleosome antibodies | Q37168030 | ||
| Chilblain lupus erythematosus--a review of literature. | Q37187524 | ||
| Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review | Q37560336 | ||
| Autoimmune diseases induced by biological agents: a double-edged sword? | Q37620986 | ||
| Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates | Q37778645 | ||
| TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists | Q37867162 | ||
| Perniosis: clinical and histopathological analysis | Q42466273 | ||
| Autoantibodies in patients with psoriatic arthritis on anti-TNFα therapy. | Q42787700 | ||
| Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers | Q46138857 | ||
| Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy | Q49031401 | ||
| Harveian Lectures on Lupus. | Q55267243 | ||
| Autoimmune Diseases Induced by TNF-Targeted Therapies | Q56907567 | ||
| Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease | Q64387132 | ||
| Drug-induced lupus erythematosus | Q64387519 | ||
| Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus | Q73961095 | ||
| Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France | Q79382745 | ||
| Antinucleosome antibodies and systemic lupus erythematosus | Q81038425 | ||
| Infliximab induced chilblain lupus in a patient with rheumatoid arthritis | Q81597343 | ||
| Chilblains and antiphospholipid antibodies: report of four cases and review of the literature | Q84124859 | ||
| Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study | Q84798365 | ||
| P433 | issue | 3 | |
| P921 | main subject | chilblains | Q2141001 |
| Chilblain lupus | Q5097618 | ||
| TNF | Q18032037 | ||
| P304 | page(s) | 563-568 | |
| P577 | publication date | 2011-12-30 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Chilblain lupus induced by TNF-α antagonists: a case report and literature review | |
| P478 | volume | 31 |
| Q27005847 | Chilblains in Southern California: two case reports and a review of the literature |
| Q36307015 | Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation |
| Q38973692 | Trigger factors of cutaneous lupus erythematosus: a review of current literature. |
| Q48298265 | Tumour necrosis factor antagonist-induced lupus: a Critically Appraised Topic. |
Search more.